Targeting Src Reactivates Pyroptosis to Reverse Chemoresistance in Lung and Pancreatic Cancer Models

Researchers demonstrated that β5-integrin repressesed chemotherapy-induced canonical pyroptosis to confer cancer chemoresistance through ASAH2-driven sphingolipid metabolic reprogramming.